Report: Physicians Overconfident in Recognizing, Treating Prescription Medication Misuse
October 17th 2019A new Health Trends study released by Quest Diagnostics has highlighted many physicians' overconfidence in their ability to identify and treat substance misuse, as well as concerns that the drug gabapentin is increasingly being misused.
Read More
New Treatment Available for “Off” Episodes in Patients with Parkinson Disease
October 16th 2019Kyowa Kirin’s istradefylline (Nourianz) is now available in the United States as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) that are experiencing “off” episodes.
Read More
Asenapine Approved as First Transdermal Patch for Treatment of Schizophrenia
October 15th 2019Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.
Read More
Tesamorelin Shown to Reverse Signs of Liver Disease in People Living with HIV
October 15th 2019Researchers at the National Institute of Health (NIH) and the Massachusetts General Hospital in Boston (MGH) found that tesamorelin reduces liver fat and prevents liver fibrosis in people living with HIV.
Read More
Varenicline Did Not Improve End-of-Treatment Abstinence in Adolescent Smokers, Study Shows
October 14th 2019A study posted in JAMA Pediatrics evaluated the efficacy and safety of varenicline tartrate for smoking cessation in adolescents and young adults. Compared with the placebo, varenicline tartrate was well-tolerated, but did not improve end-of-treatment abstinence.
Read More